EW · Edwards Lifesciences Corp · Executive Compensation

$86.32 -1.76 (-2.00%)

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$49.74B

576.40M

Volume · Sep 30 4.89M Avg daily vol (3M) 3.86M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Zovighian	Chief Executive Officer and Director	$1,192,500	—	$7,167,024	$6,499,109	$2,406,537	$189,085	$17,454,255
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$807,898	—	$2,205,238	$1,999,726	$966,435	$71,257	$6,050,554
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$635,919	—	$1,818,499	$1,648,710	$689,382	$61,829	$4,854,339
Mr. Chopra	Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies	$671,042	—	$1,764,066	$1,375,784	$824,239	$60,611	$4,695,742
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development	$759,783	—	$1,378,274	$1,249,829	$786,899	$48,580	$4,223,365
Ms. Brüls	Corporate Vice President, EMEACLA	$726,586	—	$1,020,334	$924,995	$719,581	$181,706	$3,732,107

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Zovighian	Chief Executive Officer and Director	$1,133,846	—	$6,147,250	$5,748,762	$1,451,588	$98,028	$14,579,474
Ms. Szyman	Former Corporate Vice President, Critical Care	$490,769	$1,000	$4,249,116	—	$729,760	$39,327	$5,509,972
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$774,333	—	$2,032,263	$1,900,561	$525,938	$70,088	$5,303,183
Mr. Wood	Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$778,500	—	$1,601,038	$1,500,138	$656,370	$72,615	$4,608,661
Mr. Lemercier	Former Corporate Vice President, EMEACLA	$587,253	—	$1,307,438	$1,224,484	$484,019	$165,070	$3,768,264
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development	$737,054	$4,000	$1,229,450	$1,149,042	$576,131	$51,932	$3,747,609
Mr. Chopra	Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies	$627,346	—	$1,284,500	$1,198,733	$556,133	$53,779	$3,720,491

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Zovighian	Chief Executive Officer and Director	$972,814	—	$5,099,085	$5,500,679	$1,234,207	$62,235	$12,869,020
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$743,421	—	$2,290,904	$2,308,575	$546,003	$60,250	$5,949,153
Mr. Wood	Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$763,227	—	$2,010,988	$1,898,467	$662,625	$59,727	$5,395,034
Ms. Szyman	Former Corporate Vice President, Critical Care	$672,728	$1,000	$1,479,357	$1,596,052	$552,420	$38,474	$4,340,031
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development	$721,939	—	$1,453,964	$1,566,163	$504,060	$45,673	$4,291,799
Mr. Lemercier	Former Corporate Vice President, EMEACLA	$741,355	—	$357,276	$384,317	$664,727	$214,152	$2,361,827
Mr. Mussallem	Former Chief Executive Officer and Chairman of the Board	$604,321	—	$399,972	—	$602,640	$198,804	$1,805,737

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	Former Chief Executive Officer and Chairman of the Board	$1,213,038	—	$5,583,038	$6,186,115	$869,400	$140,554	$13,992,145
Mr. Lemercier	Former Corporate Vice President, EMEACLA	$665,635	—	$2,228,867	$2,446,507	$361,414	$208,689	$5,911,112
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$704,816	—	$1,314,025	$1,457,589	$319,643	$65,326	$3,861,399
Mr. Wood	Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$695,336	$2,000	$1,165,265	$1,293,106	$337,238	$65,876	$3,558,821
Mr. Zovighian	Chief Executive Officer and Director	$641,922	—	$1,092,210	$1,209,870	$344,862	$49,563	$3,338,427
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development	$692,745	$4,000	$992,873	$1,101,414	$351,624	$47,243	$3,189,899

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	Former Chief Executive Officer and Chairman of the Board	$1,153,040	—	$5,230,175	$5,501,118	$1,581,770	$147,202	$13,613,305
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$664,688	—	$1,244,451	$1,306,053	$573,036	$81,175	$3,869,403
Mr. Wood	Corporate Vice President	$658,063	$2,000	$1,114,085	$1,170,952	$567,418	$77,726	$3,590,244
Mr. Lemercier	Corporate Vice President	$654,236	—	$693,922	$728,243	$532,209	$239,517	$3,281,649
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development	$658,091	—	$976,040	$1,026,875	$540,176	$64,329	$3,265,511

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	Chairman of the Board and Chief Executive Officer	$1,121,299	—	$3,731,409	$4,232,880	$734,993	$230,352	$10,050,933
Mr. Lemercier	Corporate Vice President	$625,360	—	$604,174	$688,517	$254,746	$246,810	$4,344,915
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$647,079	$49,583	$1,091,084	$1,236,859	$262,500	$98,860	$3,385,965
Mr. Wood	Corporate Vice President	$639,273	—	$968,369	$1,097,961	$273,000	$101,114	$3,079,717
Mr. Bobo	Corporate Vice President	$640,931	—	$856,555	$975,897	$252,000	$77,881	$2,803,264

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	Chairman of the Board and Chief Executive Officer	$1,072,240	—	$3,641,664	$4,235,402	$2,381,117	$190,550	$11,520,973
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$619,760	—	$1,047,907	$1,098,595	$756,864	$47,945	$3,571,071
Mr. Lemercier	Corporate Vice President	$576,854	—	$546,270	$633,331	$555,287	$197,453	$3,313,960
Mr. Wood	Corporate Vice President	$605,791	$4,000	$849,708	$988,184	$756,864	$88,736	$3,293,283
Mr. Bobo	Corporate Vice President	$615,455	$2,000	$807,687	$935,153	$671,600	$73,546	$3,105,441

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	Chairman of the Board and Chief Executive Officer	$1,034,769	—	$3,409,941	$3,958,800	$1,668,227	$207,212	$10,278,949
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$593,628	—	$843,514	$975,537	$559,944	$49,207	$3,021,830
Mr. Wood	Corporate Vice President	$574,430	$4,000	$804,231	$936,516	$507,683	$91,543	$2,918,403
Mr. Bobo	Corporate Vice President	$592,999	$4,000	$772,062	$891,964	$563,790	$78,584	$2,903,399

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	Chairman of the Board and Chief Executive Officer	$995,385	—	$2,943,863	$3,409,180	$2,228,226	$176,099	$9,734,099
Mr. Ullem	Corporate Vice President, Chief Financial Officer	$569,826	—	$855,664	$914,598	$800,400	$44,082	$3,184,570
Mr. Bobo	Corporate Vice President	$573,506	$2,000	$821,135	$881,474	$802,473	$68,501	$3,149,089
Mr. Wood	Corporate Vice President	$550,506	$2,000	$821,135	$880,215	$780,318	$87,602	$3,121,776

Executive changes

Person	Role	Change	Effective	Filed
Nicholas J. Valeriani	director	Appointed	2026-05-07	2026-05-08
Ramona Sequeira	director	Appointed	2026-05-07	2026-05-08
Bernard J. Zovighian	director	Appointed	2026-05-07	2026-05-08
Leslie S. Heisz	director	Appointed	2026-05-07	2026-05-08
Paul A. LaViolette	director	Appointed	2026-05-07	2026-05-08
Steven R. Loranger	director	Appointed	2026-05-07	2026-05-08
David T. Feinberg, MD	director	Appointed	2026-05-07	2026-05-08
Kieran T. Gallahue	director	Appointed	2026-05-07	2026-05-08
Leslie C. Davis	director	Appointed	2026-05-07	2026-05-08
Theodora Mistras	Corporate Vice President, Chief Financial Officer	Appointed	2026-05-29	2026-05-04
Daniel J. Lippis	Corporate Vice President responsible for Transcatheter Aortic Valve Replacement	Appointed	2025-09-01	2025-07-25
Larry L. Wood	Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	Resigned	2025-09-01	2025-07-25
David T. Feinberg, M.D.	Board of Directors	Appointed	2024-07-10	2024-07-10
Andrew M. Dahl	Senior Vice President, Principal Accounting Officer	Appointed	2024-07-01	2024-06-17
Robert W.A. Sellers	Senior Vice President, Principal Accounting Officer	Retired	2024-07-01	2024-06-17
Michael A. Mussallem	Non-Executive Chairman and a director of the Board	Retired	2024-05-07	2024-03-26
Bernard J. Zovighian	President	Appointed	2023-01-01	2022-12-08
Bernard J. Zovighian	Chief Executive Officer	Appointed	2023-05-11	2022-12-08
Michael A. Mussallem	Chief Executive Officer	Retired	2023-05-11	2022-12-08

Key facts CIK 1099800 CUSIP 28176E108 13F (30d) 34 filings 21 filers Visit website Investor relations